David Chiu1, Leif Peterson2, Mitchell S V Elkind3, Jonathan Rosand4, Linda M Gerber5, Marc D Silverstein2. 1. Methodist Neurological Institute, Weill Cornell Medical College, Houston, TX. Electronic address: dchiu@tmhs.org. 2. Methodist Neurological Institute, Weill Cornell Medical College, Houston, TX. 3. College of Physicians and Surgeons, Columbia University, New York, New York. 4. Vascular and Critical Care Neurology and Center for Human Genetic Research, Massachusetts General Hospital, Boston. 5. Weill Cornell Medical College, Department of Public Health, New York, NY.
Abstract
BACKGROUND:Intracerebral hemorrhage (ICH) is associated with a greater average initial stroke severity, higher mortality, and poorer long-term neurologic outcomes than ischemic stroke. The purpose of this study was to determine whether the poorer prognosis of ICH is independent of initial stroke severity. METHODS: We analyzed data from the Glycine Antagonist in Neuroprotection (GAIN) Americas trial, in which 1604 non-obtunded patients with acute stroke were treated within 6 hours of symptom onset irrespective of hemorrhagic (N = 237) versus ischemic (N = 1367) subtype. Multiple logistic regression analysis was performed to evaluate predictors of mortality and neurologic outcome (modified Rankin scale [mRS] score of 0-1 v 2-6 at 3 months) adjusting for baseline National Institutes of Health Stroke Scale score, stroke risk factors, clinical and demographic characteristics, and gavestinel treatment group. Multiple linear regression techniques were used to assess the impact of various predictors on the full mRS score at 3 months. RESULTS:ICH significantly increased the odds of a poor neurologic outcome (odds ratio 1.94, 95% confidence interval 1.23-3.06) and was independently associated with a mean 0.25-point increase in the 3-month mRS score (P = .04). ICH had no effect on mortality compared with ischemic stroke (odds ratio 1.01, 95% confidence interval .68-1.49) after adjusting for initial stroke severity (National Institutes of Health Stroke Scale score) and other baseline characteristics. CONCLUSIONS: Among conscious stroke patients, ICH is an independent predictor of poor neurologic outcome, nearly doubling the odds of long-term disability. However, ICH is not associated with higher mortality compared with ischemic stroke after adjusting for initial stroke severity and other baseline characteristics. Copyright (c) 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.
RCT Entities:
BACKGROUND:Intracerebral hemorrhage (ICH) is associated with a greater average initial stroke severity, higher mortality, and poorer long-term neurologic outcomes than ischemic stroke. The purpose of this study was to determine whether the poorer prognosis of ICH is independent of initial stroke severity. METHODS: We analyzed data from the Glycine Antagonist in Neuroprotection (GAIN) Americas trial, in which 1604 non-obtunded patients with acute stroke were treated within 6 hours of symptom onset irrespective of hemorrhagic (N = 237) versus ischemic (N = 1367) subtype. Multiple logistic regression analysis was performed to evaluate predictors of mortality and neurologic outcome (modified Rankin scale [mRS] score of 0-1 v 2-6 at 3 months) adjusting for baseline National Institutes of Health Stroke Scale score, stroke risk factors, clinical and demographic characteristics, and gavestinel treatment group. Multiple linear regression techniques were used to assess the impact of various predictors on the full mRS score at 3 months. RESULTS:ICH significantly increased the odds of a poor neurologic outcome (odds ratio 1.94, 95% confidence interval 1.23-3.06) and was independently associated with a mean 0.25-point increase in the 3-month mRS score (P = .04). ICH had no effect on mortality compared with ischemic stroke (odds ratio 1.01, 95% confidence interval .68-1.49) after adjusting for initial stroke severity (National Institutes of Health Stroke Scale score) and other baseline characteristics. CONCLUSIONS: Among conscious strokepatients, ICH is an independent predictor of poor neurologic outcome, nearly doubling the odds of long-term disability. However, ICH is not associated with higher mortality compared with ischemic stroke after adjusting for initial stroke severity and other baseline characteristics. Copyright (c) 2010 National Stroke Association. Published by Elsevier Inc. All rights reserved.
Authors: Martin N Kaddumukasa; Elly Katabira; Martha Sajatovic; Svetlana Pundik; Mark Kaddumukasa; Larry B Goldstein Journal: J Stroke Cerebrovasc Dis Date: 2017-08-12 Impact factor: 2.136
Authors: Lauren H Sansing; Tajie H Harris; Frank A Welsh; Scott E Kasner; Christopher A Hunter; Katalin Kariko Journal: Ann Neurol Date: 2011-10 Impact factor: 10.422
Authors: Ruth Tangonan; Ronald Alvarado-Dyer; Andrea Loggini; Faten El Ammar; Ruchit Kumbhani; Christos Lazaridis; Christopher Kramer; Fernando D Goldenberg; Ali Mansour Journal: Neurocrit Care Date: 2022-01-24 Impact factor: 3.532
Authors: Amar Dhand; Catherine E Lang; Douglas A Luke; Angela Kim; Karen Li; Liam McCafferty; Yi Mu; Bernard Rosner; Steven K Feske; Jin-Moo Lee Journal: Neurorehabil Neural Repair Date: 2019-09-15 Impact factor: 3.919
Authors: Gustavo W Kuster; Lívia A Dutra; Israel P Brasil; Evelyn P Pacheco; Márcio A C Arruda; Cristiane Volcov; Renan B Domingues Journal: Stroke Res Treat Date: 2014-12-11